BioSpace News Archive

Synthekine Inc today announced that data from a Phase 1a/1b clinical trial of its α/β biased IL-2 partial agonist, STK-012, will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2024 taking place in San Diego, from April 5-10, 2024.

Neuroelectrics announced today study results published to the preprint server medRxiv that suggest tele-supervised at-home transcranial direct current stimulation (tDCS) using Starstim over the left dorsolateral prefrontal cortex (L-DLPFC) may improve the clinical symptoms of major depressive disorder (MDD).

Neuronetics, Inc. announced an expanded commercial partnership with Transformations Care Network, one of the nation’s largest mental health care providers.

Inhibikase Therapeutics, Inc. today announced that Dr. Milton Werner, President and Chief Executive Officer of Inhibikase Therapeutics, will present an update on the of the 201 Trial evaluating risvodetinib (“risvo”) at the 2024 AD/PD Meeting being held March 5-9, 2024 in Lisbon, Portugal.

Telomir Pharmaceuticals, Inc. today announced that Telomir, alongside its partner Frontage Laboratories, presented a scientific poster at the National University Health System of Singapore (NUHS) Centre for Healthy Longevity Conference 2024.

IceCure Medical Ltd. today announced that the Company’s Chief Executive Officer, Eyal Shamir , will present at the 34th Annual Oppenheimer Healthcare MedTech & Services Conference on Tuesday, March 12, 2024, at 8:00am EST.

Johnson & Johnson (NYSE: JNJ) announced today it has successfully completed the acquisition of Ambrx Biopharma, Inc.

HabitNu, the health and wellness company that connects community-based Diabetes Prevention Program (DPP) providers with those in need of services, was awarded a $14M, five-year cooperative agreement with the Centers for Disease Control (CDC).

SurGenTec proudly announces the first implantations and 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its revolutionary OsteoFlo HydroPutty Synthetic Bone Graft.

AB Science SA is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Science development.